From an Identified Risk to Regulatory Measures: Implementation of HLA-B★5701 Screening Before Abacavir Treatment

被引：0
|
作者：
N. Cachin
C. Kreft-Jais
机构：
[1] Afssaps,
来源：
Drug Safety | 2008年 / 31卷 / 10期
关键词：
Nucleoside Analogue; Abacavir; Regulatory Measure; Skin Patch; Identify Risk;
D O I：
10.2165/00002018-200831100-00046
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：885 / 885
相关论文
共 50 条
  • [1] From an Identified Risk to Regulatory Measures: Implementation of HLA-B*5701 Screening Before Abacavir Treatment
    Cachin, N.
    Kreft-Jais, C.
    [J]. DRUG SAFETY, 2008, 31 (10) : 902 - 902
  • [2] Screening for HLA-B*5701 carriage before treatment by abacavir in reunion island
    Ricard, C.
    Ricaud, C.
    Poubeau, P.
    Gaud, C.
    [J]. TISSUE ANTIGENS, 2008, 71 (04): : 375 - 375
  • [3] A new and simple method for HLA-B*5701 screening before abacavir treatment
    Bortolozzo, Katia
    Boschetto, Chiara
    Hajman, Karla
    Cesaro, Loretta
    Mason, Silvia
    Baroncelli, Marta
    Sestini, Roberta
    Porfirio, Berardino
    [J]. TISSUE ANTIGENS, 2010, 75 (05): : 541 - 542
  • [4] HLA-B*5701 screening for hypersensitivity to abacavir
    Mallal, Simon
    Phillips, Elizabeth
    Carosi, Giampiero
    Molina, Jean-Michel
    Workman, Cassy
    Tomazic, Janez
    Jaegel-Guedes, Eva
    Rugina, Sorin
    Kozyrev, Oleg
    Cid, Juan Flores
    Hay, Phillip
    Nolan, David
    Hughes, Sara
    Hughes, Arlene
    Ryan, Susanna
    Fitch, Nicholas
    Thorborn, Daren
    Benbow, Alastair
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06): : 568 - 579
  • [5] HLA-B*5701 screening for hypersensitivity to abacavir
    Faruki, Hawazin
    Lai-Goldman, Myla
    [J]. PERSONALIZED MEDICINE, 2008, 5 (03) : 297 - 300
  • [6] HLA-B*5701 screening for susceptibility to abacavir hypersensitivity
    Lucas, Andrew
    Nolan, David
    Mallal, Simon
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) : 591 - 593
  • [7] Implementation of HLA-B*5701 genetic screening prior to abacavir prescription in Georgia
    Dvali, N.
    Chkhartishvili, N.
    Sharvadze, L.
    Dzigua, L.
    Karchava, M.
    Gatserelia, L.
    Tsertsvadze, T.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E244 - E245
  • [8] HLA-B*5701 and abacavir hypersensitivity
    Watson, ME
    Pimenta, JM
    Spreen, WR
    Hernandez, JE
    [J]. PHARMACOGENETICS, 2004, 14 (11): : 783 - 784
  • [9] Should HLA-B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?
    Park, Wan Beom
    Choe, Pyoeng Gyun
    Song, Kyoung-Ho
    Lee, Shinwon
    Jang, Hee-Chang
    Jeon, Jae Hyun
    Park, Sang-Won
    Park, Myoung Hee
    Oh, Myoung-don
    Choe, Kang Won
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (03) : 365 - 367
  • [10] Screening for HLA-B*5701 reduces the frequency of abacavir hypersensitivity reactions
    Reeves, I.
    Churchill, D.
    Fisher, M.
    [J]. ANTIVIRAL THERAPY, 2006, 11 (07) : L11 - L11
12345